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Abstract  
This paper presents the results of the study of the 
interrelationships of polymorphic loci of chemokines 
(rs1719153, rs4512021, rs2107538, rs2857657, 
rs1801157) with features of humoral immunity in 
patients with chronic glomerulonephritis. It was 
established that the concentration of immunoglobulins 
A and G in the group of patients with chronic 
glomerulonephritis was significantly higher than in the 
control group (p<0.001). It was revealed that the 
genotype +1931TT CCL4 (rs1719153) is a marker of an 
increased level of immunoglobulin G in patients with 
chronic glomerulonephritis (p=0.05). 
 
Keywords: Chronic Glomerulonephritis, Chemokines, 
Gene Polymorphism, Immunoglobulins, Chronic 
Kidney Disease. 
 
Introduction 
Chronic glomerulonephritis (CGN) holds a special place 
in the structure of chronic kidney diseases as one of the 
main causes of terminal renal failure and associated 
disability and mortality (Litovkina et al., 2014; Sorokina 
et al., 2016). According to available data, 
glomerulonephritis is considered as an immune-
mediated renal disease with diffuse proliferative-
exudative lesion of the glomerular apparatus of the 
kidneys, caused by imbalance of regulatory mechanisms 
of immunocompetent cells and renal glomerulus cells 
with the involvement of other components of the kidney 
tissue in the pathological process (Dudnyk et al., 2015; 
Nekipelova et al., 2016). Despite the fact that the role of 
the main classes of immunoglobulins (Ig) in the 
development of CGN is currently undoubtable, there are 
relatively few publications devoted to studies of 
immunoglobulin in CGN, available in the literature. 
Immunoglobulins are classified as specific humoral 
immunity factors that specifically recognize a wide 
variety of antigens, interact with other 
immunocompetent cells having corresponding 
receptors, and activate the complement system (Arias et 
al., 2013).  
The Ig level in peripheral blood is one of the often tested 
parameters of the immune system, characterizing the 
immune status in normal state and in 
immunopathological disorders (Floccari et al., 2007). 
Therefore, interest in the study of immunological 
indicators such as IgA, IgM, IgG is not accidental, but is 
caused by the desire to evaluate the humoral unit of the 
immune response in patients with CGN. 
A diversity of clinical manifestations of CGN, 
significant differences in the rate of decrease in renal 
function with the same severity of risk factors allows us 
to discuss the importance of the genetic component in 
the formation of a predisposition to this disease and 
determination of the features of its course. According to 
modern literature data, among the candidate CGN genes, 
chemokines are especially prominent (Azmandian et al., 
2012). Chemokines are peptide low-molecular 
immunomodulators with chemoattractant properties 
(Stangou et al., 2016). They control the migration of 
different types of leukocytes with the relevant receptors 
from the bloodstream to the tissues, inflammation and 
autoimmune process foci, participate in activation and 
differentiation of leukocytes, angiogenesis, fibrogenesis 
(Wada, 2008; Eddy, 2014). However, the results of 
molecular genetic studies of chronic glomerulonephritis 
of different authors often differ and do not give an 
unambiguous answer to the question of the pathogenetic 
role of individual polymorphisms of chemokine genes 
(Bagci et al., 2015; Dudnyk et al., 2015; Sorokina et al., 
2016). 
The objective of this research was to study the 
interrelationships of polymorphic loci of chemokines 
(rs1719153, rs4512021, rs2107538, rs2857657, 
rs1801157) with features of humoral immunity in 
patients with chronic glomerulonephritis. 
 
Materials and Methods 
For the study, a sample of 700 people was formed: 238 
patients with chronic glomerulonephritis and 462 
individuals of the control group. Samples of patients and 
controls included Russian residents of the Central 
Chernozem Region of the Russian Federation, who had 
no family ties with each other. Patients belonged to the 
corresponding group after being diagnosed with the 
disease, confirmed by clinical and laboratory-
instrumental methods of examination in the nephrology 
department of St. Joasaph Belgorod Regional Clinical 
Hospital. Exclusion criteria for a group of CGN patients 
were diabetes mellitus (in history or identified by the test 
results) and hypertension. All patients signed an 
informed consent for inclusion in the study and use of 
their data. The control group included individuals 
without kidney disease and hypertension. 
As the material for the study we used 8-9 ml of venous 
blood taken from the cubital vein of a proband. A 
genomic DNA was isolated from peripheral blood by the 
method of standard phenol-chloroform extraction 
(Miller et al., 1988). Analysis of the investigated loci 
was carried out by the method of polymerase chain 
reaction of DNA synthesis with the use of standard 
primers and probes. 
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The level of immunoglobulins A, M and G was 
determined by enzyme immunoassay (ELISA) in serum 
samples with standard sets in accordance with the 
manufacturer's instructions. 
The test materials were processed by statistical methods 
using Statistica 8.0. The correspondence of the observed 
distribution of genotypes to the expected one was 
analyzed with the use of 2 criterion, based on the 
Hardy-Weinberg equilibrium. A comparative analysis 
of the allele and genotype frequencies of the loci studied 
between the control group and patients used the χ2 
criterion with the Yates correction for continuity. The 
calculations were made in 2x2 conjugation tables. 
Statistical differences were considered significant at 
p<0.05. 
 
Results and Discussion 
During the study of 238 patients with chronic 
glomerulonephritis and 462 individuals of the control 
group a full comparability of sample data in terms of 
age, nationality and place of birth was established. 
We conducted a molecular genetic typing of the 
following polymorphic loci: +1931A/Т ССL4 
(rs1719153), A/G CXCL11 (rs4512021), -403A/G 
CCL5 (rs2107538), C/G CCL2 (rs2857657), -801G/A 
CXCL12 (rs1801157). The selection of genetic marker 
data was determined by the pathogenetic significance of 
chemokine determinants for CGN (Anders et al., 2010). 
The study of the frequencies of alleles of studied 
polymorphisms of chemokine genes revealed that for all 
loci in the group of CGN patients and in the control 
sample the empirical distribution of genotypes 
corresponds to the theoretically expected one at Hardy-
Weinberg equilibrium (p> 0.05). 
A comparative analysis of the frequency distribution of 
alleles and genotypes of polymorphic markers of 
chemokine genes showed no statistically significant 
differences between the patients with CGN and those of 
the control group (р>0.05). 
Further, the levels of immunoglobulins A, M, G were 
studied in patients with CGN. It was found that patients 
with CGN had a higher content of immunoglobulins A 
(3.75 g/l) and G (18.85 g/l) compared to the control 
group (2.98 g/l and 12.42 g/l, respectively, p<0.001). 
The level of immunoglobulin M in patients and in 
control group was the same (p>0.05). 
The study of the interrelations of genetic chemokine 
polymorphisms with the level of immunoglobulins in 
patients with CGN revealed statistically significant 
associations of the polymorphic genetic locus + 
1931A/T CCL4 (rs1719153) with the level of 
immunoglobulin G (Table 1). Individuals with the 
genotype +1931TT CCL4 had concentration of 
immunoglobulin G equal to 22.02-2.02 g/l, which is 
significantly higher than in the patients with genotypes 
+1931AA and + 1931AT CCL4 (18.530.59 g/l, 
p=0.05). 
 Genotypes 
Concentration of Immunoglobulins (g/l) 
IgA IgM IgG 
rs4512021 
AA 3.640.23 2.92 0.14 19.01 0.87 
AG, GG 3.82 0.19 2.82 0.12 18.82 0.84 
p 0.39 0.74 0.81 
rs2107538 -403GG 3.65 0.17 2.99  0.10 21.14 0.75 
-403AA, -403GA 3.77 0.25 2.84 0.15 18.52 1.01 
p 0.29 0.60 0.36 
rs2857657 CC 3.85 0.14 2.81 0.09 18.98 0.58 
CG, GG 3.49 0.94 2.84 0.61 18.77 2.68 
p 0.60 0.70 0.85 
rs1801157 -801GG 3.60 0.16 2.800.11 18.71 0.98 
-801GA, -801AA 4.070.26 2.860.15 19.500.71 
p 0.12 0.51 0.40 
rs1719153 +1931 ТТ 3.490.39 2.950.18 22.022.02 
+1931AA, +1931AT 3.820.31 3.050.96 18.530.59 
p 0.49 0.57 0.05 
Notes: SNP, single-nucleotide polymorphism; IgA, immunoglobulin A; IgM, immunoglobulin M; IgG, immunoglobulin 
G. 
Table 1. The Level of Immunoglobulins in Patients with Chronic Glomerulonephritis (g/l), Depending on the 
Genetic Polymorphisms of Chemokines 
 
Helix Vol. 8(5): 3666- 3668 
 
 
3668 Copyright © 2018 Helix ISSN 2319 – 5592 (Online) 
 
According to modern literature sources, among 
chemokines, a macrophage inflammatory protein-1 
plays a significant role in the development of 
inflammatory reactions in the body (Stasikowska et al., 
2007). This chemokine is a low-molecular protein of the 
β-family of CC-chemokines. CCL4, along with the 
chemoattractant property (predominantly for CD8+ 
cells) induces the attachment of circulating human 
lymphocytes to the endothelium (Stasikowska et al., 
2007). There is evidence of an increase in the level of 
CCL3 in individuals with coronary artery disease 
(Ardigo et al., 2005) and CCL4 in those with breast 
cancer (Chavey et al., 2007). The available literature on 
the role of CCL4 in CGN in humans is very limited. A 
significant increase in the level of CCL3 and CCL4 in 
the peripheral blood of patients with diabetic 
glomerulonephritis was described (Stasikowska et al., 
2007). It should be noted that the available literature 
contains no works devoted to the study of the 
interrelations of polymorphic loci of chemokines with 
the levels of immunoglobulins A, M and G in patients 
with chronic glomerulonephritis. 
 
Conclusion 
Thus, within the framework of this paper, the study of 
associations of polymorphic loci of chemokines 
(rs1719153, rs4512021, rs2107538, rs2857657, 
rs1801157) with features of humoral immunity in 
patients with chronic glomerulonephritis, residing in the 
Central Chernozem Region of Russia, established that 
the genotype +1931TT CCL4 (rs1719153) with a higher 
level of immunoglobulin G in patients with chronic 
glomerulonephritis (p=0.05). It was established that the 
concentration of immunoglobulins A and G in the group 
of patients with chronic glomerulonephritis was 
significantly higher than in the control group (p<0.001). 
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